These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30522955)

  • 1. Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents.
    Marinelli L; Fornasari E; Di Stefano A; Turkez H; Genovese S; Epifano F; Di Biase G; Costantini E; D'Angelo C; Reale M; Cacciatore I
    Bioorg Med Chem Lett; 2019 Jan; 29(2):194-198. PubMed ID: 30522955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogues of the neuroprotective tripeptide Gly-Pro-Glu (GPE): synthesis and structure-activity relationships.
    Alonso De Diego SA; Muñoz P; González-Muñiz R; Herranz R; Martín-Martínez M; Cenarruzabeitia E; Frechilla D; Del Río J; Jimeno ML; García-López MT
    Bioorg Med Chem Lett; 2005 May; 15(9):2279-83. PubMed ID: 15837309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in inflammation is associated with the protective effect of Gly-Pro-Glu and cycloprolylglycine against Aβ-induced depletion of the hippocampal somatostatinergic system.
    Aguado-Llera D; Canelles S; Fernández-Mendívil C; Frago LM; Argente J; Arilla-Ferreiro E; López MG; Barrios V
    Neuropharmacology; 2019 Jun; 151():112-126. PubMed ID: 30981749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (R)-α-Lipoyl-Gly-l-Pro-l-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease.
    Marinelli L; Fornasari E; Di Stefano A; Turkez H; Arslan ME; Eusepi P; Ciulla M; Cacciatore I
    Neuropeptides; 2017 Dec; 66():52-58. PubMed ID: 28993014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in Hippocampal Amyloid-β Peptide (Aβ) Content during Glycine-Proline-Glutamate (Gly-Pro-Glu) Co-Administration Is Associated with Changes in Inflammation and Insulin-like Growth Factor (IGF)-I Signaling.
    Frago LM; Burgos-Ramos E; Rodríguez-Pérez M; Canelles S; Arilla-Ferreiro E; Argente J; López MG; Barrios V
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model.
    Minelli A; Conte C; Cacciatore I; Cornacchia C; Pinnen F
    Amino Acids; 2012 Sep; 43(3):1359-67. PubMed ID: 22218995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity.
    Alonso De Diego SA; Gutiérrez-Rodríguez M; Pérez de Vega MJ; González-Muñiz R; Herranz R; Martín-Martínez M; Cenarruzabeitia E; Frechilla D; Del Río J; Jimeno ML; García-López MT
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3396-400. PubMed ID: 16650992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury.
    Sizonenko SV; Sirimanne ES; Williams CE; Gluckman PD
    Brain Res; 2001 Dec; 922(1):42-50. PubMed ID: 11730700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer's Disease.
    Turkez H; Cacciatore I; Marinelli L; Fornasari E; Aslan ME; Cadirci K; Kahraman CY; Caglar O; Tatar A; Di Biase G; Hacimuftuoglu A; Di Stefano A; Mardinoglu A
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33478054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and neuroprotective activity of analogues of glycyl-L-prolyl-L-glutamic acid (GPE) modified at the alpha-carboxylic acid.
    Trotter NS; Brimble MA; Harris PW; Callis DJ; Sieg F
    Bioorg Med Chem; 2005 Jan; 13(2):501-17. PubMed ID: 15598572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Gly-Pro-Glu (GPE) analogues: expedite solid-phase synthesis and biological activity.
    Alonso De Diego SA; Gutiérrez-Rodríguez M; Pérez de Vega MJ; Casabona D; Cativiela C; González-Muñiz R; Herranz R; Cenarruzabeitia E; Frechilla D; Del Río J; Jimeno ML; García-López MT
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1392-6. PubMed ID: 16321525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPE and GPE analogues as promising neuroprotective agents.
    Cacciatore I; Cornacchia C; Baldassarre L; Fornasari E; Mollica A; Stefanucci A; Pinnen F
    Mini Rev Med Chem; 2012 Jan; 12(1):13-23. PubMed ID: 22070686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of side chain modified glutamic acid analogues of the neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE).
    Brimble MA; Trotter NS; Harris PW; Sieg F
    Bioorg Med Chem; 2005 Jan; 13(2):519-32. PubMed ID: 15598573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of macrocyclic analogues of the neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE).
    Harris PW; Brimble MA
    Org Biomol Chem; 2006 Jul; 4(14):2696-709. PubMed ID: 16826294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of glycine-modified analogues of the neuroprotective agent glycyl-L-prolyl-L-glutamic acid (GPE).
    Lai MY; Brimble MA; Callis DJ; Harris PW; Levi MS; Sieg F
    Bioorg Med Chem; 2005 Jan; 13(2):533-48. PubMed ID: 15598574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties.
    Cacciatore I; Fornasari E; Di Stefano A; Marinelli L; Cerasa LS; Turkez H; Aydin E; Moretto A; Ferrone A; Pesce M; di Giacomo V; Reale M; Costantini E; Di Giovanni P; Speranza L; Felaco M; Patruno A
    Eur J Med Chem; 2016 Jan; 108():553-563. PubMed ID: 26717205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.
    Saura J; Curatolo L; Williams CE; Gatti S; Benatti L; Peeters C; Guan J; Dragunow M; Post C; Faull RL; Gluckman PD; Skinner SJ
    Neuroreport; 1999 Jan; 10(1):161-4. PubMed ID: 10094155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.
    Guan J; Gluckman PD
    Br J Pharmacol; 2009 Jul; 157(6):881-91. PubMed ID: 19438508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats.
    Guan J; Thomas GB; Lin H; Mathai S; Bachelor DC; George S; Gluckman PD
    Neuropharmacology; 2004 Nov; 47(6):892-903. PubMed ID: 15527823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.